A pharmaceutical composition for vaginal application comprising up to 2% by weight relative to the total weight of the composition of at least one sex steroid precursor selected from the group consisting of dehydroepiandrosterone, dehydroepiandrosterone sulfate, and androst-5-ene-3ß,17ß-diol and a pharmaceutically acceptable excipient, diluent or carrier.